Siegfried Holding AG (SWX:SFZN)

Market Cap	4.15B -1.1%
Revenue (ttm)	1.29B +0.8%
Net Income	154.10M +19.2%
EPS	3.51 +17.5%
Shares Out	43.77M
PE Ratio	27.00
Forward PE	23.92
Dividend	0.38 (0.40%)
Ex-Dividend Date	Apr 22, 2025

Volume	171,664
Average Volume	174,022
Open	95.50
Previous Close	95.90
Day's Range	93.70 - 95.90
52-Week Range	53.70 - 107.40
Beta	0.71
RSI	71.17
Earnings Date	Feb 20, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 3,926
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SFZN

Financial Performance

In 2024, Siegfried Holding AG's revenue was 1.29 billion, an increase of 1.82% compared to the previous year's 1.27 billion. Earnings were 160.06 million, an increase of 41.93%.